Roos-Hesselink Jolien W, Tobler Daniel, Warnes Carole
1Department of Cardiology,Erasmus MC,Rotterdam,The Netherlands.
2Department of Cardiology,University Hospital Basel,University of Basel,Basel,Switzerland.
Cardiol Young. 2017 Dec;27(10):2025-2028. doi: 10.1017/S1047951117002220.
For the first time in 2017 adults with CHD was included in the World Congress of Pediatric Cardiology & Cardiac Surgery. With growing numbers and more complex patients reaching adulthood, there is a growing need for more attention to this subspecialty. Although survival is excellent and now over 90% of patients reach adulthood, many have residual problems and complications. Heart failure and arrhythmias are most commonly encountered. Life-expectancy is nearly normal for mild lesions, but remains reduced in moderate-complex lesions and re-interventions are often needed. As most patients want to live a normal life, sports participation and pregnancy become very important issues. Finally, although innovative treatments are being developed, including for end-stage heart failure, we have to refine strategies for optimal care, including during the end-stage lives of our patients. This article provides an overview of a selection of topics in the field of adults with CHD presented during the 2017 Seventh World Congress of Pediatric Cardiology & Cardiac Surgery (WCPCCS) in Barcelona.
2017年，患有冠心病的成年人首次被纳入世界儿科心脏病学与心脏外科学会。随着成年冠心病患者数量的增加以及病情愈发复杂，对这一亚专业的关注需求也日益增长。尽管患者生存率很高，如今超过90%的患者能活到成年，但许多人仍有残留问题和并发症。心力衰竭和心律失常最为常见。轻度病变患者的预期寿命接近正常，但中度复杂病变患者的预期寿命仍会缩短，且常常需要再次干预。由于大多数患者希望过上正常生活，参与体育运动和怀孕就成为非常重要的问题。最后，尽管包括针对终末期心力衰竭的创新治疗方法正在研发，但我们必须完善优化治疗策略，包括在患者生命终末期。本文概述了在2017年于巴塞罗那召开的第七届世界儿科心脏病学与心脏外科学会（WCPCCS）期间提出的一系列冠心病成年患者领域的主题。
